Might money spent on statins be better spent?

BMJ 2003; 327 doi: http://dx.doi.org/10.1136/bmj.327.7420.933-b (Published 16 October 2003)
Cite this as: BMJ 2003;327:933.3

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Arnold J Jenkins, general practitioner principal (AJ_Jenkins@compuserve.com)
  1. Colne Road Surgery, Burnley BB10 1LG

    EDITOR–As Abbasi argues in his Editor's choice, the benefits of publishing negative findings should be obvious.1

    As a general practitioner I wonder how many million pounds sterling the NHS could save if the Medical Research Council, the British Heart Foundation, and the Lancet shared this view. An example is in the prescribing of statins. They are a major cost in my practice, as I am sure they are to many practitioners.

    Even in general practice I recognised …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL